U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06851988) titled 'Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients' on Feb. 21, 2024.
Brief Summary: Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
Study Start Date: May 03, 2023
Study Type: INTERVENTIONAL
Condition:
Aging
High-intensity Interval Training
Head and Neck Cancers - Tonsils...